Loss of microrna-135b enhances bone metastasis in prostate cancer and predicts aggressiveness in human prostate samples

10Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

About 70% of advanced-stage prostate cancer (PCa) patients will experience bone metasta-sis, which severely affects patients’ quality of life and progresses to lethal PCa in most cases. Hence, understanding the molecular heterogeneity of PCa cell populations and the signaling pathways associated with bone tropism is crucial. For this purpose, we generated an animal model with high penetrance to metastasize to bone using an intracardiac percutaneous injection of PC3 cells to identify PCa metastasis-promoting factors. Using genomic high-throughput analysis we identified a miRNA signature involved in bone metastasis that also presents potential as a biomarker of PCa progression in human samples. In particular, the downregulation of miR-135b favored the incidence of bone metastases by significantly increasing PCa cells’ migratory capacity. Moreover, the PLAG1, JAKMIP2, PDGFA, and VTI1b target genes were identified as potential mediators of miR-135b’s role in the dissemination to bone. In this study, we provide a genomic signature involved in PCa bone growth, contributing to a better understanding of the mechanisms responsible for this process. In the future, our results could ultimately translate into promising new therapeutic targets for the treatment of lethal PCa.

References Powered by Scopus

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

11207Citations
N/AReaders
Get full text

Microenvironmental regulation of tumor progression and metastasis

5997Citations
N/AReaders
Get full text

Predicting effective microRNA target sites in mammalian mRNAs

5569Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Prostate cancer bone metastases biology and clinical management (Review)

13Citations
N/AReaders
Get full text

New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials

11Citations
N/AReaders
Get full text

Differential Expression of miRNAs Contributes to Tumor Aggressiveness and Racial Disparity in African American Men with Prostate Cancer

11Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Olivan, M., Garcia, M., Suárez, L., Guiu, M., Gros, L., Méndez, O., … Santamaria, A. (2021). Loss of microrna-135b enhances bone metastasis in prostate cancer and predicts aggressiveness in human prostate samples. Cancers, 13(24). https://doi.org/10.3390/cancers13246202

Readers' Seniority

Tooltip

Researcher 4

67%

PhD / Post grad / Masters / Doc 2

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 5

63%

Agricultural and Biological Sciences 2

25%

Medicine and Dentistry 1

13%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 15

Save time finding and organizing research with Mendeley

Sign up for free